250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Health Care Startup Investors in Denmark in October 2023

A list of 50 angel investors and VC (Venture Capital) funds that invest in Health care startups based in Denmark. We rank investors based on the number of investments they made in Health care companies from Denmark. We update this investor list every month.

Top 50 Health Care Startup Investors in Denmark in October 2023

Investor Health Care Denmark investments
Novo Holdings 21
Vaekstfonden 17
BioInnovation Institute 15
PreSeed Ventures 14
Seed Capital 13
Vaekstfonden 13
Sunstone Life Science Ventures 10
People Ventures 6
VF Venture 4
Gilde Healthcare 4
West Hill Capital 4
Oskare Capital 3
Innovation Fund Denmark 3
HealthCap 3
Sofinnova Partners 3
EIR Ventures 3
Sweet Capital 3
Crista Galli Ventures 3
byFounders 3
RA Capital Management 3
Bruce Linton 2
Alexander Rindom-Andersen 2
Crowberry Capital 2
Aescap Venture 2
Industrifonden 2
Karolinska 2
VentureFriends 2
Inventure 2
Wellington Partners 2
Investo Capital 2
CAPNOVA 2
M Ventures 2
Ysios Capital 2
14W 2
Lundbeckfonden Ventures 2
CBC Investment Group 2
Christian Dörffer 2
Novo Ventures 2
Balderton Capital 2
Stine Molgaard Sorensen 2
Johnson & Johnson Development Corporation 2
Thomas Ryge Mikkelsen 2
Wellcome Trust 1
Alta Partners 1
The Aventures 1
SR One 1
Index Ventures 1
Teknoinvest 1
NOON Ventures 1
Norgine Ventures 1

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 19 investments in the past 12 months

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom

Portfolio highlights

  • Octave — Octave is a national behavioral health practice that’s creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics in California and New York, the company offers personalized care plans that can include individual therapy, couples therapy, and groups, while pioneeringrelationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.
  • Acesion Pharma — Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
  • Alentis Therapeutics — Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
Show more investments...

Vaekstfonden
VC Fund · Hellerup, Hovedstaden, Denmark · 13 investments in the past 12 months

Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Funding Round, Pre-Seed
  • Denmark, United States, United Kingdom

Portfolio highlights

  • Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
  • QuadSAT — QuadSAT provides antenna and RF measurements with state-of-the-art equipment, including a drone platform with payload and custom software.
  • kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Show more investments...

BioInnovation Institute
VC Fund · Copenhagen, Hovedstaden, Denmark · 16 investments in the past 12 months

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Convertible Note, Debt Financing, Pre-Seed
  • Denmark, Germany, Switzerland

Portfolio highlights

  • TriptoBIO — TriptoBIO is developing a platform for producing natural plant compounds that will support the health of our planet. Our goal is to create a future where everyone can benefit from the power of plants, without depleting natural resources. Our first compound will liberate the world from rat poison
  • MATR Foods — MATR Foods is a food-tech startup that provides fungi-based food ingredients offering dishes produced from fungi like mushrooms, vegetables, and fruits.
  • Agrobiomics — Agrobiomics is a danish Agritech start-up, harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
Show more investments...

PreSeed Ventures
VC Fund · Lyngby, Hovedstaden, Denmark · 6 investments in the past 12 months

PreSeed Ventures is the biggest and most succesful early stage investor in Denmark. For more than 20 years, PreSeed Ventures have assisted and financed talented entrepreneurs with early-stage investments, and we hold more than 70 companies in our portfolio.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Pre-Seed, Funding Round
  • Denmark, United States, United Kingdom

Portfolio highlights

  • Jabbr — Jabbr allows to capture boxing matches with a virtual video production.Its goal is to make video production and advanced performance analytics in combat sports available to anyone with a smartphone.
  • Marts — Marts is an integrated platform that enhances the capacities of IT departments by eliminating these inefficiencies. Put unconnected systems and intimidating spreadsheets behind. IT asset management, support services, and procurement are all integrated into one platform by Marts.
  • NORTHSTAKE — Providing institutional investors with access to future economies through secure and trustworthy investment pathways for digital assets
Show more investments...

Seed Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 4 investments in the past 12 months

Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.

Show more...

Investment focus

  • Software, Health Care, SaaS
  • Seed, Funding Round, Series A
  • Denmark, United States, United Kingdom

Portfolio highlights

  • Embla — Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.
  • Lunar — Get a free account and card - just like 750,000 others. Spend smart. Achieve financial peace of mind. Sign up in minutes.
  • Landfolk — Landfolk is the new marketplace for the special holiday homes that are hidden around the country. We have hand-picked every single cottage, where there are proud and passionate hosts, who love their holiday homes, but also like to share it with others.
Show more investments...

Vaekstfonden
VC Fund · Hellerup, Hovedstaden, Denmark · 13 investments in the past 12 months

Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Denmark, United States, Norway

Portfolio highlights

  • Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
  • QuadSAT — QuadSAT provides antenna and RF measurements with state-of-the-art equipment, including a drone platform with payload and custom software.
  • kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Show more investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in the past 12 months

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Funding Round, Series B, Series A
  • Denmark, Sweden, Switzerland

Portfolio highlights

  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show more investments...

People Ventures
VC Fund · Taastrup, Hovedstaden, Denmark · 2 investments in the past 12 months

People Ventures are your dreamcast team of co-founders, investors, executives, engineers, academics and industry experts. Together with talented entrepreneurs — We shape fantastic businesses through operational and commercial execution.

Show more...

Investment focus

  • Health Care, Internet of Things, Software
  • Seed, Pre-Seed, Series A
  • Denmark, Sweden, United States

Portfolio highlights

  • Tiimo — Tiimo helps you manage your daily life and improve your wellbeing. Visualize your day. Improve your routines. Stress less.
  • Uniify — Uniify is a no-code customer onboarding software that makes it fast, easy and secure for financial companies to onboard their customers. Save your business time and money, and build onboarding flows for your customers in minutes instead of months.
  • LEIA — LEIA is an application that provides postpartum support for new parents.
Show more investments...

VF Venture
VC Fund

Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.

Show more...

Investment focus

  • Software, Biotechnology, SaaS
  • Seed, Funding Round, Series A
  • Denmark, United Kingdom, Iceland

Portfolio highlights

  • Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
  • Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
  • Onomondo — Onomondo is a global IoT network. Our IoT SIM and cloud platform future proof your devices with full data transparency, freedom to leave, and no third parties.
Show more investments...

Gilde Healthcare
VC Fund · Utrecht, Utrecht, The Netherlands · 6 investments in the past 12 months

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series C, Series B, Series A
  • United States, The Netherlands, Germany

Portfolio highlights

  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • GT Medical Technologies — At GT Medical Technologies, our purpose is Improving the Lives of Patients with Brain Tumors. GammaTile Therapy is Surgically Targeted Radiation Therapy (STaRT) for patients with brain tumors.
Show more investments...

West Hill Capital
VC Fund · London, England, United Kingdom

West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.

Show more...

Investment focus

  • Information Technology, Software, Health Care
  • Seed, Funding Round, Series A
  • United Kingdom, Denmark

Portfolio highlights

  • Skyline Partners — Skyline Partners | Closing the Global Coverage Gap through Innovative Parametric Insurance Solutions.
  • ATLANT 3D Nanosystems — Micro and nanodevices are built and tested within days instead of months or years.
  • Whistleblower Software — A Whistleblower Software system made for accountants and lawyers that have clients, the whistleblower software system helps businesses implement a compliant solution that is both secure and transparent. their products are reporting links, case management, partner account they have designed a journey that makes feel safe about the process. AWS ishandling the physical security of the infrastructure, whistleblower software takes the shared responsibility of security between our cloud infrastructure and application seriously.
Show more investments...

Oskare Capital
VC Fund · Paris, Ile-de-France, France · 1 investment in the past 12 months

Oskare Capital is a venture capital firm.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Seed, Pre-Seed, Series A
  • Italy, Denmark, United Kingdom

Portfolio highlights

  • Leva Clinic — Leva Clinic offers health care services for people with chronic pain. Their medical services include back pain, cancer pain, endometriosis, facial pain, fibromyalgia, joint pain, knee pain, multiple sclerosis, sciatica, and so on.
  • Octarine Bio — Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.
  • Herbolea Biotech — Unique bio-processing technologies NATURAL, SOLVENT-LESS Botanical extraction Learn more
Show more investments...

Innovation Fund Denmark
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in the past 12 months

Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Grant, Pre-Seed, Seed
  • Denmark, United States

Portfolio highlights

  • Tryp.com — There is always a reason to go! We use artificial intelligence to find the best travel deals at the lowest price. The algorithm compares and connects flights, trains, and buses to create the perfect multidestination trips with matching hotel offers.
  • Curvature AI — Grow your revenue with discounts and special offers selected and optimized by AI.
  • Breye Therapeutics — Protecting the Gift of Sight
Show more investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in the past 12 months

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France

Portfolio highlights

  • Hemab — Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Show more investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 21 investments in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom

Portfolio highlights

  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show more investments...

EIR Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investment in the past 12 months

EIR Ventures is a new Life Science Venture Group in the Nordics.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Seed, Funding Round
  • Denmark, Sweden, United States

Portfolio highlights

  • Henlez — Henlez is a Danish startup company.
  • Synklino — Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection. The company's immunotoxin is highly effective, potent and fast-acting that kills lytic and latently infected cells, enabling patients to have long-term health benefits for transplantation.
  • Pretzel Therapeutics — Welcome To A New Era In Mitochondrial Therapeutics. Developing treatments to address the genetic roots of mitochondrial dysfunction.
Show more investments...

Sweet Capital
VC Fund · Stockholm, Stockholms Lan, Sweden

Sweet is the King.com (Candy Crush) founders' investment fund. We are passionate about funding the next generation of entrepreneurs focused on creating a positive impact through consumer technology.

Show more...

Investment focus

  • Apps, Software, Mobile
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Israel

Portfolio highlights

  • Pachama — Harnessing AI to drive carbon capture and protect global forests
  • The Expert — Book consultations with the world's top design experts
  • Masters — Train mind and body on the Masters app with full workout programs designed and run by the world's best athletes. Join today and start training like a pro.
Show more investments...

Crista Galli Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in the past 12 months

Crista Galli Ventures invests in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.

Show more...

Investment focus

  • Health Care, Wellness, Medical
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Denmark

Portfolio highlights

  • Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
  • Subtle Medical — Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.
  • Pear Bio — Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
Show more investments...

byFounders
VC Fund · Copenhagen, Hovedstaden, Denmark · 7 investments in the past 12 months

byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.

Show more...

Investment focus

  • Software, Artificial Intelligence, Mobile Apps
  • Seed, Series A, Pre-Seed
  • Denmark, United States, Germany

Portfolio highlights

  • QA.tech — Our AI combines the skills of a QA engineer with the speed of automated testing for you. This shortens your time to market, cuts costs and improves the quality of your web apps.
  • Rig.dev — Rig.dev offers an open-source application platform for Kubernetes. Rig.dev empower developers to work in their own environments with elevated application abstractions, while still leveraging Kubernetes's reliability, portability, and scalability.
  • Jellatech — Jellatech is a B2B biotech business based in Raleigh, NC, and with R&D in Wageningen, Netherlands. Jellatech is producing high-quality, pure, animal-free collagen and gelatin. Founded by a group of innovators, dreamers, entrepreneurs, and scientists, Jellatech is eliminating the dependency on animals, to make better ingredient products -starting with collagen and gelatin.
Show more investments...

RA Capital Management
VC Fund · Boston, Massachusetts, United States · 40 investments in the past 12 months

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, United Kingdom, China

Portfolio highlights

  • Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
  • Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
  • SAB Biotherapeutics — A biopharmaceutical development company leading the science and manufacturing of antibody therapeutics. Utilizing some of the most advanced antibody science in the world, SAB is delivering the world’s first large-scale platform to create immunoglobulins. This natural production platform holds the potential for treatment of public health problems,rare conditions, long-term diseases and global pandemic threats.
Show more investments...

Bruce Linton
Angel · Ottawa, Ontario, Canada

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

Show more...

Investment focus

  • Health Care, Cannabis, Biotechnology
  • Seed, Post-IPO Equity, Pre-Seed
  • Canada, United States, Denmark

Portfolio highlights

  • Omura — Discover heat-not-burn technology with Omura's dry herb vaporizer devices. Explore sustainable vaping options for hemp & whole flower CBD.
  • Octarine Bio — Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.
  • Martello Technologies — Prioritize and resolve performance problems and optimize the Microsoft 365 and Teams user experience with Martello Vantage DX.
Show more investments...

Alexander Rindom-Andersen
Angel

Alexander Rindom-Andersen is the Co-founder & CEO @ Naetion

Show more...

Investment focus

  • Mobile, Software, Freelance
  • Pre-Seed
  • Denmark

Portfolio highlights

  • HJAELP — Marketplace, Digital Workplace, Mobile App
  • Naetion — Marketplace, Digital Workplace, Mobile App, Web3
Show more investments...

Crowberry Capital
VC Fund · Reykjavík, Gullbringusysla, Iceland · 4 investments in the past 12 months

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

Show more...

Investment focus

  • Software, Gaming, Information Technology
  • Seed, Pre-Seed, Series A
  • Iceland, Denmark, United States

Portfolio highlights

  • Embla — Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.
  • SNERPA Power — SNERPA Power develops intelligent energy services.
  • Ellie.ai — Grasp your business needs and validate your product ideas before building your data pipelines. Use Ellie's conceptual data models and logical data models to design great data products.
Show more investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

Show more...

Investment focus

  • Biotechnology, Pharmaceutical, Chemical
  • Series A, Series B, Funding Round
  • United Kingdom, Austria, Belgium

Portfolio highlights

  • Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
  • Avantium — Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands.Avantium's proprietary high-throughput technology enables a faster and morecost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development.Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields:new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent.Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business.Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.
  • F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Show more investments...

Industrifonden
VC Fund · Stockholm, Stockholms Lan, Sweden · 8 investments in the past 12 months

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

Show more...

Investment focus

  • Software, Biotechnology, Information Technology
  • Funding Round, Series A, Seed
  • Sweden, United States, Denmark

Portfolio highlights

  • Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
  • Retein — Aquammodate is a greentech company that produces highly pure water at minimum energy cost.
  • Open Payments — Open Payments connects you to multiple banks through one single unified API. This removes the complexity and frictions of many diverse integrations
Show more investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 3 investments in the past 12 months

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Seed, Series A
  • Sweden, Denmark, United States

Portfolio highlights

  • Henlez — Henlez is a Danish startup company.
  • OssDsign AB — OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and materials researchers and engineers. The key people in the company are presented below. OssDsign has in addition developed a network of international experts in ClinicalAffairs, Regulatory and Business Development.
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Show more investments...

VentureFriends
VC Fund · Athens, Attiki, Greece · 9 investments in the past 12 months

We are an early stage investor investing in Seed and Series A startups.

Show more...

Investment focus

  • FinTech, Software, E-Commerce
  • Seed, Series A, Funding Round
  • Greece, United Kingdom, United States

Portfolio highlights

  • Embat — Keep your cash flows, cash accounts, debt positions and forecasts monitored and automated real time.
  • Embla — Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.
  • Measurlabs — We provide testing services for any material, product, or chemical, helping product developers and quality managers get the information they need about their products.
Show more investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Finland, Sweden, Denmark

Portfolio highlights

  • Haltian — End-to-end IoT solutions and world-glass product design services from Haltian
  • Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.
  • Value.Space — Space based risk assessments & monitoring
Show more investments...

Wellington Partners
VC Fund · Munich, Bayern, Germany · 3 investments in the past 12 months

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Germany, United States, United Kingdom

Portfolio highlights

  • Nosto — Use Powerful Personalization Made Easy on e-Commerce Platforms. Nosto generates a 10-30% Average Increase in Revenue.
  • Minervax — MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein : click to read more
  • Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
Show more investments...

Investo Capital
VC Fund · Aalborg, Nordjylland, Denmark

Investo Capital is a Danish venture capital firm based in Aalborg. They invest in carefully selected Danish early-growth companies within tech business areas in the broad sense. The target group is innovative companies with proof of business, strategic thinking, and strong growth prospects in Denmark. Strategic corporate concepts and competentmanagement are essential features. The investment focus is Technology, IT, SAAS- and med-tech.

Show more...

Investment focus

  • Health Diagnostics, Computer, Software
  • Seed
  • Denmark

Portfolio highlights

  • Tentoma — Professional packaging machines. Horizontal stretch film packaging machines and innovative industrial wrapping and packaging equipment.
  • Create it REAL — Tailored 3D printing solutions. Enabled by our REALvision software, our electronics, and quality partner products.
  • Brainreader — Volumetric brain assessment software for detection of brain atrophies & abnormalities. In depth analysis of brain MRI. Contact Brainreader.
Show more investments...

CAPNOVA
VC Fund · Aarhus, Midtjylland, Denmark

They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.

Show more...

Investment focus

  • Software, Information Technology, Internet
  • Funding Round, Seed, Pre-Seed
  • Denmark, United States, India

Portfolio highlights

  • Ulobby — Ulobby is an automated tool for stakeholder management and political monitoring
  • Mechanic Miner — Mechanic Miner is a 2D construction/survival game with mechanical steam-powered machines. You are stranded on a strange and forbidding planet, where survival is made difficult by hostile animals and plant life. From your home world you did bring a multitool, which is able to craft any kind of machine part - provided the requisite rawmaterials can be found. Relying solely on the technology you brought, you set out to explore a whole world. You can progress through the game by acquiring new types of steam-powered technology elements, that are necessary to delve deeper into the diverse biomes of the planet, and perhaps, ultimately, discover the means to escape. You can construct any kind of machine of your own design - and any kind of machine can be simulated by the game's physics engine - and of course, designs can be shared with your friends.
  • ResoTher Pharma — ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin 1A as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role.
Show more investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 17 investments in the past 12 months

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom

Portfolio highlights

  • CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
  • BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show more investments...

Ysios Capital
VC Fund · San Sebastian, Pais Vasco, Spain · 3 investments in the past 12 months

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Spain, United States, Switzerland

Portfolio highlights

  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Show more investments...

14W
VC Fund · New York, New York, United States · 4 investments in the past 12 months

14W is a Venture Capital firm based in New York, focusing on the intersection of technology and consumer behaviour.

Show more...

Investment focus

  • E-Commerce, Fashion, Marketplace
  • Seed, Series A, Series B
  • United States, United Kingdom, Spain

Portfolio highlights

  • Wallapop — Wallapop is a hyper-local mobile marketplace for buying and selling secondhand goods, primarily accessible via a mobile app. It uses a geo-localized technology that connects a community of 15 million users by offering an easy and convenient way to buy and sell items that are no longer used. The platform, which has found a second home for more than180 million items, provides people with access to unique goods at great prices while extending the life of fully functional products. Since its inception, Wallapop has been committed to continuous innovation in the online classifieds industry and second-hand market and aspires to use technology to contribute to sustainability. The company is backed by investors Korelya Capital, NAVER, Accel, Insight Venture Partners, 14W, and Northzone. It was founded in Barcelona, Catalonia, Spain by Agustin Gomez, Miguel Vicente, and Gerard Olive in 2013.
  • Cayena — Cayena is a B2B marketplace for the $100b+ wholesale food industry in Latin America. The company allows restaurants, bars, bakeries, hotels and dark kitchens to procure their inventory from multiple suppliers with next day delivery and a comprehensive suite of add-on services.
  • The Bank of London — The Bank of London home page.
Show more investments...

Lundbeckfonden Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investment in the past 12 months

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, United Kingdom, France

Portfolio highlights

  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Aura Biosciences — Aura Biosciences is pioneering a first-in-class technology to treat a wide variety of solid tumor types. We are initially pursuing cancers where patients are in need of a transformational change in treatment options, such as choroidal melanoma, so they can avoid choosing between preserving their life or their vision
  • LEXEO Therapeutics — LEXEO Therapeutics is a fully integrated biotechnology company. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine. Beyond LEXEO Therapeutics’ lead programs – which are focused on both rare and non-rare monogenic (singlegenemutation) diseases – the company’s preclinical pipeline spans monogenic diseases, as well as hereditary and acquired diseases across a spectrum of patient population sizes and a range of unmet medical needs. Importantly, LEXEO Therapeutics will focus on advancing clinical programs through to commercialization, with the goal of maintaining an ongoing research collaboration with Weill Cornell Medicine’s Department of Genetic Medicine to help advance the company’s pre-clinical pipeline.
Show more investments...

CBC Investment Group
VC Fund · Gothenburg, Vastra Gotaland, Sweden

CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.

Show more...

Investment focus

  • Biotechnology, Software, SaaS
  • Funding Round, Seed, Series B
  • Sweden, Denmark, Germany

Portfolio highlights

  • GLX Analytix — GLX Analytix is ​​a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
  • Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
  • Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.
Show more investments...

Christian Dörffer
Angel · Lisbon, Lisboa, Portugal

Christian Dörffer is the Investor at Metafy, CEO and Co-Founder at Sweet Capital, and Founder and Chairman at Midnight Runners. He is a former Founder and Partner at BAMCAP. He attended Copenhagen Business School.

Show more...

Investment focus

  • Apps, Software, Mobile
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Israel

Portfolio highlights

  • BESE — Our mission is to broaden and reshape the cultural narrative by shining light on the untold stories that reflect today's America.
  • Wave Sports + Entertainment — Wave Sports + Entertainment is a media company building brands, original content, talent, and products for the next generation of digital super fans.
  • Simple Feast — Simple Feast operates as an online cookbook platform. Aside from this, they also offer plant-based food that is sustainably produced and organic, delivered straight at consumer's doorstep. At Simple Feast, they offer Weekly Boxes and Comfort Food Boxes. Weekly Boxes are three nights of entire vegetarian or vegan meals that require a few stepsof preparation. Comfort Food Boxes are monthly offerings of 4 to 8 complete jarred meals that only require heating up and your favorite side dish.Founded in 2015 by Jakob Jønck and Thomas Ambus, the company is headquartered in Copenhagen, Denmark.
Show more investments...

Novo Ventures
VC Fund · Bagsværd, Hovedstaden, Denmark

Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.Novo A/S was established in 1999 prior to the demerger of Novo NordiskA/S, where Novozymes A/S was established as a stand-alone publicly listed company. Novo's purpose and objectives are to manage the Foundation's financial assets and to ensure the Foundation sufficient dividends to cover its grant obligations for medical and scientific research etc. in Scandinavia.Novo A/S attains these objectives through:compliance with the rules and principles which are set out in the Articles of Association of the Novo Nordisk Foundation regarding exercise of the voting rights of A and B shares in Novo Nordisk A/S and Novozymes A/S, respectively, assurance that all companies in which the company has a material influence actively contribute to the development of the Novo Group and operate their business in accordance with the visions and values of the Novo Group, maintenance of a material influence on Novo Nordisk A/S and Novozymes A/S, and investment and financing business including placing of capital in companies and real property domestically and abroad.Novo’s overall investment strategy is thus to maintain ownership of Novo Nordisk’ and Novozymes’ shares at a level just above 25% and to invest dividends from these companies and other income in the life science area as well as in a broad portfolio of financial assets.Novo A/S has since 1999 established itself as an international venture capital partner in the life science area and has invested in over 50 companies in Denmark, Europe and North America. Through its financial investment activities Novo A/S seeks to spread the company’s total financial risk and at the same time to ensure a high return taking into consideration the chosen risk profile. In 2007 Novo A/S together with the Novo Nordisk Foundation established ‘Novo Seeds’. The new program (split into two sub-programs) is aimed at supporting early stage applied research in the life science area in Scandinavia. At the beginning of 2009 Novo A/S launched a new initiative, investing 'growth equity' into promising later stage/commercial stage life science companies. Novo A/S represents the interests of the Novo Nordisk Foundation through participation on the boards of the companies in the Novo Group.The companies in the Novo Group are members of a 'family of companies', independently managed, but sharing a set of common values as set out in the 'Charter for Companies in the Novo Group'. In the Charter these core values, commitments and management principles that companies in the Novo Group should live up to are described.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, Switzerland

Portfolio highlights

  • INBRACE — Swift Health Systems is a stealth stage medical device company developing INBRACE: a revolutionary, easy to use, wide indication, personalized orthodontic system hidden behind the teeth. Our patented self-guiding technology uses light and continuous forces to gently correct your smile with less pain and fewer doctor visits. INBRACE is FDAregistered and a catalyst for disruption in orthodontics. INBRACE increases the number of people who will seek orthodontic treatment by addressing the top concerns for patients while driving practice growth for clinicians. Our platform leverages digital treatment planning, computer modeling, and direct digital manufacturing to create a scalable, patient customized solution that delivers the standard of care across the entire range of orthodontic cases.
  • Theraxyte — Theraxyte is an innovative nano-drug developer. It focuses on the R&D and application of new nano-drugs, especially innovative drugs.
  • Amolyt Pharma — We are building on our team's established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases.
Show more investments...

Balderton Capital
VC Fund · London, England, United Kingdom · 24 investments in the past 12 months

In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.

Show more...

Investment focus

  • Software, FinTech, Financial Services
  • Series A, Series B, Series C
  • United Kingdom, United States, Germany

Portfolio highlights

  • JOKR — Grocery shopping is easier now with JOKR, your instant delivery app. Order your groceries and favorite products in our online supermarket and get them instantly at your door. Download the app now and make your first grocery order on us. Available in IOs and Android. Access www.jokr.com for more info
  • Writer — Accelerate growth across every team with the most secure AI platform. We customize generative AI to your workflows, not the other way around.
  • Anytype — for those who celebrate trust & autonomy.
Show more investments...

Stine Molgaard Sorensen
Angel · Copenhagen, Hovedstaden, Denmark · 1 investment in the past 12 months

Stine Molgaard Sorensen is the Co-founder and COO of Radiobotics.

Show more...

Investment focus

  • Robotics, Software, Health Care
  • Pre-Seed
  • Denmark

Portfolio highlights

  • NordInsight — NordInsight is a browser-based implant database, you can reduce the risk to MRI scan patients. Scan confidently alongside renowned medical facilities throughout the globe.
  • Radiobotics — Our flagship product RBfracture is able to detect fractures in X-rays across the entire appendicular skeleton, and is MDR IIa certified. Also available: RBhip, RBknee and RBmarker
Show more investments...

Johnson & Johnson Development Corporation
VC Fund · New Brunswick, New Jersey, United States

JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series C, Series B, Series A
  • United States, United Kingdom, Canada

Portfolio highlights

  • CVRx — CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left andright carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.
  • Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
  • Osteal Therapeutics — Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Show more investments...

Thomas Ryge Mikkelsen
Angel · Copenhagen, Hovedstaden, Denmark

Thomas Ryge Mikkelsen is an Investor and Chairman at Nøie.

Show more...

Investment focus

  • E-Commerce, Beauty, Fashion
  • Seed, Series A, Funding Round
  • Denmark

Portfolio highlights

  • NØIE — Noie is a consumer goods company that offers cosmetics and skincare products. The company offers customized a customized skincare platform that combines deep dermatological knowledge with feedback from the community and the users' individual needs to eliminate guesswork and coincidence in the search for skincare that actually works.
  • SON OF A TAILOR — SON OF A TAILOR is a Denmark-based company that provides its clients with customized T-shirt tailoring services. The company is based in Copenhagen, Hovedstaden.
Show more investments...

Wellcome Trust
VC Fund · London, England, United Kingdom · 1 investment in the past 12 months

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Grant, Series C, Funding Round
  • United States, United Kingdom, Germany

Portfolio highlights

  • DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
  • Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
  • Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Show more investments...

Alta Partners
VC Fund · San Francisco, California, United States · 3 investments in the past 12 months

Alta Partners is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series C, Series A
  • United States, United Kingdom, Spain

Portfolio highlights

  • Allakos — Allakos develops antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 immune response plays a key role in pathology, including allergic disease, inflammation, and diseases characterized by excess production of inflammatory cells. Its antibodies target cell types implicated in allergic and inflammatoryresponses. Allakos was founded in 2012 and is headquartered in San Carlos, California.
  • BetterVet — At BetterVet.com, we believe pets deserve more than just a regular vet visit. We provide high quality mobile veterinary care. Book pet appointments online now!
  • Novome Biotechnologies — Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The Company has developed the first-ever platform for controlled colonization of the gut with engineered bacteria, enabling first-in-class living therapeutics: Genetically Engineered MicrobialMedicines (GEMMs). Novome is utilizing its proprietary GEMMs platform in its lead preclinical program in hyperoxaluria, which is focused on the development of a therapeutic strain of bacteria that degrades oxalate to prevent the formation of kidney stones. Efforts are also directed to the expansion of its proprietary synthetic biology platform into additional indications.
Show more investments...

The Aventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investment in the past 12 months

The team comes from heavy tech oriented background such as Cloud Infrastructure, Data Science, Theoretical Physics, Machine Learning, Software Development and Business development. We like to brand ourselves as "the nerds" in the tech space. We speak the same technical language as the founders and like to be an active part in the venturewe enter, depending on the needs of the founders. Our thesis is that we are building bridge spanning over the knowledge gap between deeptech founders and traditional investors.

Show more...

Investment focus

  • Financial Services, FinTech, Cryptocurrency
  • Seed, Series B, Private Equity
  • Denmark, United States, Norway

Portfolio highlights

  • Firi — Buy and sell bitcoin and other cryptocurrencies for NOK. We are registered as an exchange and custodian for cryptocurrency in Denmark.
  • Capsule — CAPSULE wardrobe app I rediscover your wardrobe I style and create outfits I follow wardrobes for styling inspiration
  • Frankly Insure — Digital, simple and transparent P2P & decentralised insurance – powered by people, deep tech and IoT.
Show more investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 4 investments in the past 12 months

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, United Kingdom, Canada

Portfolio highlights

  • Rezo Therapeutics — Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence. Rezo's proprietary platform can be used to treat a wide range of diseases. Rezo's initial focus is oncology, with plans to expand into other therapeutic areas through collaborations and partnerships.
  • ADARx Pharmaceuticals — ADARx is a genetic medicine company focusing on the editing of Messenger RNA Targeting transcripts and oligonucleotide-based therapeutics.
  • Odyssey Therapeutics — Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for patients with cancer inflammatory diseases
Show more investments...

Index Ventures
VC Fund · San Francisco, California, United States · 32 investments in the past 12 months

Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.

Show more...

Investment focus

  • Software, E-Commerce, Internet
  • Series A, Series B, Seed
  • United States, United Kingdom, France

Portfolio highlights

  • Ideogram — Ideogram: Helping people become more creative.
  • Worldover — Cosmetic compliance made simple
  • SafetyCulture — Raise your game with an easy to use mobile app and software inspection solution. iAuditor by SafetyCulture is available on iOS and Android.
Show more investments...

Teknoinvest
VC Fund · Oslo, Oslo, Norway

Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series B, Series A, Funding Round
  • Sweden, Norway, United States

Portfolio highlights

  • GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
  • SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
  • Sol Voltaics — Sol Voltaics informs consumers and experts about solar panels. We have complete solar panel guides helping to design, set up, install,l and maintain your panels.
Show more investments...

NOON Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark

Noon Ventures is a Copenhagen-based, early-stage venture investor established in 2020. We invest in proven transformative technologies with the potential to impact environmental or climate challenges.

Show more...

Investment focus

  • Electronics, Biotechnology, Semiconductor
  • Seed
  • Denmark

Portfolio highlights

  • SpectroInlets — SpectroInlets enables measurements of dissolved gases for liquid environments, allowing for new measurement applications.
  • Enduro Genetics — Bioproduction can be difficult to scale to large cultivation volumes while keeping titers high. By applying game-changing synthetic biology technology, Enduro Genetics empowers our partner companies to maximize performance of all cells cultivated from their production strains.
  • Lotus Microsystems — Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug andplay solutions enable our customers to innovate their electronics without worrying about power supply units.
Show more investments...

Norgine Ventures
VC Fund · Uxbridge, Hillingdon, United Kingdom

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Funding Round, Debt Financing, Series A
  • France, United Kingdom, United States

Portfolio highlights

  • ImaginAb — ImaginAb is a pioneering biotech company, innovating for tomorrow with modern radiopharmaceutical advances. Our advanced imaging solutions like CD8 ImmunoPET are aimed to accelerate the progress of physicians all over the world, ending the need for repeat, painful biopsies.
  • PathoQuest — PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing
  • Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
Show more investments...
Investors by industry
Investors by country
Investors in Denmark by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck